HEALTH PROBLEMS — INFECTION

SORT date author clear filters


FILTER RECORDS BY


al-Razi (10th century CE; 4th century AH)
Kitab al-Hawi fi al-tibb [The comprehensive book of medicine].

View

Nettleton T (1722)
Part of a letter from Dr. Nettleton, physician at Halifax, to Dr. Jurin, R. S. Sec concerning the inoculation of the small pox, and the mortality of that distemper in the natural way. Philosophical Transactions of the Royal Society of London (1722-1723) 32:209-212.

View

Massey I (1723)
A short and plain account of inoculation. With some remarks on the main argument made use of to recommend that practice, by Mr. Maitland and others. To which is added, a letter to the learned James Jurin, M.D.R.S. Secr. Col. Reg. Med. Lond. Soc. London: W. Meadows.

View

Jurin J (1724)
A letter to the learned Dr. Caleb Cotesworth, F. R. S. of the College of Physicians, London, and physician to St. Thomas's Hospital; containing a comparison between the danger of the natural small pox, and that given by inoculation. Philosophical Transactions of the Royal Society of London (1722 - 1723), 32:213-227.

View

Boylston Z (1726)
Historical account of the small-pox inoculated in New-England, upon all sorts of persons, whites, blacks, and of all ages and constitutions. London: Printed for S. Chandler.

View

Cassem Algaida Aga (1729)
Paper relating to the inoculation of the small-pox, as it is practised in the Kingdoms of Tripoli, Tunis, and Algier. In: Scheuchzer JG. An account of the success of inoculating the small-pox in Great Britain, for the years 1727 and 1728. London: J. Peele, pp 61-63.

View

Scheuchzer JG (1729)
An account of the success of inoculating the small-pox in Great Britain, for the years 1727 and 1728: With a comparison between the mortality of the natural small-pox, and the miscarriages in that practice; as also some general remarks on its progress. London: J.Peele.

View

Berkeley G (1752)
Farther thoughts on tar-water. In: Bishop of Cloyne. A miscellany, containing several tracts on various subjects. London: Tonson and Draper.

View

de la Condamine C-M (1754)
Mémoire sur l'inoculation de la petite vérole. Lu a l'assemblée publique de l'Académie royale des sciences, le mercredi 24 avril 1754. Paris: Durand.

View

Franklin B (1759)
Some account on the success of inoculation for the small-pox in England and America. London: W Strahan.

View

Vage (1759)
An extract of a letter from Mr Vage, dated at Senegal, Oct. 15, 1759. Medical Observations and Inquiries 1764;2. London: William Johnston, pp 269-272.

View

Repertoire du Regi[s]tre CC (1761)
Maladies Vénériennes, et la Chambre Noble [Venereal diseases, and the City Council]. Archives d’Etat de Genève, Arch. Hosp. Aa 104, 18 janvier, p 53, and 6 décembre, pp 135-6.

View

Lind J (1762)
An essay on the most effectual means of preserving the health of seamen, in the Royal Navy. London: D Wilson.

View

Lind J (1763)
Two papers on fevers and infection. London: D Wilson.

View

Watson W (1768)
An account of a series of experiments, instituted with a view of ascertaining the most successful method of inoculating the smallpox. London: J Nourse.

View

Lind J (1771)
An essay on diseases incidental to Europeans in hot climates. London: Becket and De Hondt.

View

Sims J (1774)
A discourse on the best methods of prosecuting medical enquiries. London: J Johnson, p78-9, 80, 86-88, 99-101.

View

Millar J (1779)
Observations on the management of the prevailing diseases particularly in the Army and Navy. London, for the author.

View

Clark J (1780)
Observations on fevers, especially of the continued type. London: T Cadell.

View

Black W (1782)
An historical sketch of medicine and surgery from their origin to the present time. London: J Johnson.

View

McCausland R (1783)
Facts and observations on different medical subjects. Medical Commentaries viii (1781/82), 247-96.

View

Haygarth J (1784)
An inquiry into how to prevent smallpox. Chester and London.

View

Fowler T (1786)
Medical reports of the effects of arsenic in the cure of agues, remitting fevers and periodic headachs. London: J Johnson, pp 105-107.

View

Hunter J (1788)
A treatise on the venereal disease. London: G Nicol and J Johnson, pp 69-70.

View

Percival T (1788)
Essays medical, philosophical and experimental Vol 1.4th ed. Warrington: Eyres, for London: Johnson.

View

Black W (1789)
An arithmetical and medical analysis of the diseases and mortality of the human species. London: J Johnson.

View

Robertson R (1789)
Observations on jail, hospital, or ship fever. New ed. London: for the Author.

View

Robertson R (1790)
Essay on fever. London: printed for the author.

View

Fordyce G (1793)
An attempt to improve the evidence of medicine. Transactions of a Society for the Improvement of Medical and Chirurgical Knowledge.  London: J Johnson.

View

Haygarth J (1793)
Sketch of a plan to exterminate the casual smallpox from Great Britain; and to introduce general inoculation. London: J Johnson

View

Rowley W (1793)
The causes of a great number of deaths amongst adults and children. 2nd edn. London: Newbery.

View

Gordon A (1795)
A treatise on the epidemic puerperal fever of Aberdeen. In: Churchill F, ed (1849). Essays on the puerperal fever and other diseases selected from the writings of British authors previous to the close of the eighteenth century. London: Sydenham Society, p 445-500.

View

Sutton D (1796)
The Inoculator; or Suttonian system of inoculation, fully set forth in a plain and familiar manner. London: Printed for the author.

View

Currie J (1797)
Medical reports on the effects of water, cold and warm, as a remedy in fever, and febrile diseases. Liverpool and London: M’Creery and Cadell.

View

Fordyce G (1798)
A third dissertation on fever, Parts I & II. London: J Johnson.

View

Jenner E (1798)
An enquiry into the causes and effects of the variolae vaccinae. London: S Low.

View

Millar J (1798)
Observations on the management of diseases in the Army and Navy in reply to Dr. Monroe. London: for the Author.

View

Millar J (1798)
Observations on the conduct of the war. An appeal to the people of Great Britain. London: for the author.

View

Jenner E (1801)
The origin of the vaccine inoculation. Printed by DN Shury, Berwick Street, Soho.

View

Fordyce G (1802)
A second dissertation on fever. London: J Johnson.

View

Fordyce G (1803)
A fifth dissertation on fever. London: J Johnson.

View

Haygarth J (1803)
A letter to Dr Percival on the prevention of infections, fevers… Annals of Medicine. Vol II, Lustrum II, 51-78.

View

Currie W (1804)
Medical reports of the effects of water: cold and warm as a remedy in fever and febrile diseases. Vol. 2. London: M’Creery & Cadell.

View

Cuming R (1805)
On the use of aqua frigida in scalds, in epidemic ophthalmia, and the effects of cold on the human body. Medical and Physical Journal. 14:239-241.

View

Pearson G, Nihell L, Nelson T, Keate T, Forster T, Carpue JC, Doratt J, Rivers F, Brand EA, de Bruyn P, Heaviside J, Payne T, Sancho W (1805)
Original Vaccine Pock Institution. Edinburgh Medical and Surgical Journal 1:513-515.

View

Sutton T (1806)
A practical account of remittent fever. London: Robinson, p 16-17.

View

Falconer W (1807)
A practical dissertation on the effects of the medicinal effects of the Bath waters. London and Bath: Robinson & Crutwell. 3rd edition Bath: Meyler and London: Robinson, pp 29, 40-41, 50-52, 72-74, 99, 101, 106, 115-116, 117, 124.

View

Blane G (1813)
Observations on the comparative prevalence, mortality, & treatment of different diseases.... Medico-chirurgical Transactions, Vol 4, p 89-141, London.

View

Mills T (1813)
An essay on the utility of bloodletting in fever Dublin: J.Barlow, for Gilbert and Hodges, London: Longman, Hurst, Rees, Orme and Brown.

View

Lesassier Hamilton A (1816)
Dissertatio Medica Inauguralis De Synocho Castrensi [Inaugural medical dissertation on camp fever]. Edinburgh: J Ballantyne.

View

MacGrigor J (1816)
Sketch of the medical history of the British armies in the peninsula of Spain and Portugal, during the late campaigns. Medico-chirurgical Transactions 6:381-489.

View

MacLean C (1818)
Results of an Investigation, respecting Epidemic and Pestilential Diseases. Vol. 2. London: Underwood.

View

Double FJ (1820)
Considérations thérapeutiques sur une nouvelle préparation de quinquina. Revue médicale, 6ème livraison.

View

Bigelow J (1835)
A discourse on self-limited diseases, delivered before the Massachusetts Medical Society at their annual meeting, May 27, 1835. Boston: Nathan Hale p 8-10.

View

Louis PCA (1835)
Recherches sur les effets de la saignée dans quelques maladies inflammatoires et sur l'action de l'émétique et des vésicatoires dans la pneumonie [Research on the effects of bloodletting in some inflammatory illnesses and on the action of emetics and blistering in pneumonia]. Paris: Librairie de l'Académie royale de médecine.

View

Louis PCA (1837)
The applicability of statistics to the practice of medicine. London Medical Gazette 20 :488-491.

View

Gavarret LDJ (1840)
Principes généraux de statistique médicale: ou développement des régles qui doivent présider à son emploi [General principles of medical statistics: or the development of rules that must govern their use]. Paris: Bechet jeune & Labé.

View

Forbes J (1846)
Homoeopathy, allopathy and “young physic”. British and Foreign Medical Review 225-265.

View

Thomson TRH (1846)
On the value of quinine in African remittent fever. Lancet 47:244-245.

View

Bryson A (1847)
Report on the Climate and Principal Diseases of the African Station. London: Printed by order of the Lords Commissioners of the Admiralty.

View

Tessier JP (1852)
De la médication homoeopathique [On homoeopathic medication]. Paris: JB Ballière.

View

Balfour TG (1854)
Quoted in West C. Lectures on the Diseases of Infancy and Childhood. London, Longman, Brown, Green and Longmans, p 600.

View

Bryson A (1854)
On the prophylactic influence of quinine. Medical Times and Gazette 8:6-7.

View

Treatment Committee of the Medical Council (1855)
Report on the results of the different methods of treatment pursued in epidemic cholera. [Metropolitan Report and Report on the Provinces throughout England and Scotland]. Report to the General Board of Health. London: Her Majesty’s Stationery Office.

View

McShane C (1856)
Medical Statistical Returns of the African Station. In: Statistical Report of the Health of the Royal Navy for the year 1856. London: House of Commons, pp 82-83.

View

Baikie WB (1856)
Narrative of an exploring voyage up the rivers Kwora and Binue in 1854. London: John Murray.

View

Thompson T (1859)
Observations on the administration of ozonized oils. Medical and Chirurgical Transactions 42:349-360.

View

Semmelweis I (1861)
Die Aetiologie, der Begriff und die Prophylaxis des Kindbettfiebers. [The etiology, concept, and prophylaxis of childbed fever]. Budapest and Vienna; Hartleben.

View

Béclard PA (1863)
Rapport général sur les prix décernés en 1862 [General report on the prizes awarded in 1862]. Mémoires de l’Académie Impériale de Médecine XXVI, Paris: Ballière, pp. xxii-xxxv.

View

Flint A (1863)
A contribution toward the natural history of articular rheumatism; consisting of a report of thirteen cases treated solely with palliative measures. American Journal of the Medical Sciences 46:17-36.

View

Barclay AW (1864)
Medical errors: fallacies connected with the application of the inductive method of reasoning to the science of medicine. London: Churchill, p 55 and 71-73.

View

Bennett JH (1865)
The restorative treatment of pneumonia. Edinburgh, AC Black.

View

Bernard C (1865)
Introduction à l'étude de la médicine expérimentale [Introduction to the study of experimental medicine]. Paris: Flammarion.

View

Sutton HG (1865)
Cases of rheumatic fever treated for the most part by mint water. Guy’s Hospital Reports 2:392-428.

View

Jürgensen T (1866)
Klinische Studien über die Behandlung des Abdominalytyphus mittelst des kalten wassers [Clinical studes on the treatment of abdominal typhus with cold water]. Leipzig, Vogel, pviii.

View

Lister J (1870)
Effects of the antiseptic system of treatment upon the salubrity of a surgical hospital. Lancet 1:4-6 and 40-42.

View

Maclagan T (1876)
The treatment of acute rheumatism by salicin. Lancet 1:383-84.

View

Wanscher O (1877)
Om Diphteritis og Croup - særligt med hensyn til Tracheostomien ved samme. [On diphtheria and croup - especially regarding tracheostomy in this condition]. Disputats [Thesis]. Jacob Lund: Kjøbenhavn, p 67-68.

View

Keith T (1878)
Results of ovariotomy before and after antiseptics. BMJ 2;590-593. doi:10.1136/bmj.2.929.590.

View

Pasteur L (1881)
Compte rendu sommaire des expériences rates á Pouilly-le-Fort, prés Melun, sur la vaccination charbonneuse [A summary account of experiences at Pouilly-le-Fort, near Mélun, on anthrax vaccination]. Comptes rendus de l'Académie des Sciences 92: 1378-1383.

View

Fry HD (1887)
The value of the antiseptic method in obstetric practice and its application to the forceps operation. JAMA 8:388-390.

View

O’Dwyer J (1887)
Fifty cases of croup in private practice treated by intubation of the larynx, with a description of the method and of the dangers incident thereto. Medical Record 32:557-561.

View

Andrew J (1891)
Harveian Oration. London: Adlard and Son. p 16-19.

View

Dymock W, Warden CJH, Hooper D (1891)
A history of the principal drugs of vegetable origin met with in British India. Pharmacographia Indica Vol. II. London: Kegan Paul, Trench, Trübner, pp 180-181.

View

Behring EA, Boer NN, Kossel H (1893)
Zur Behandlung diphtheriekranker Menschen mit Diphtherieheilserum [On the treatment of diphtheria patients with curative diphtheria serum]. Deutsche Medicinische Wochenschrift 17:389-39.

View

Roux E, Martin L, Chaillou A (1894)
Trois cent cas de diphthérie traité par le serum antidiphthérique. Annales de l’Institut Pasteur 8:640-661.

View

Priestley J (1895)
On the value of eucalyptus oil as a disinfectant in scarlet fever. Lancet 1:861-863.

View

Brown EH (1896)
Cholera and its treatment by preventive inoculation in the Darbhanga Jail. Indian Medical Gazette, July, 247-250.

View

Finsen NR (1896)
Om Anvendelse I Medicinen af koncentrerede kemiske Lysstraaler. [On the application in medicine of concentrated chemical rays of light]. Kjøbenhavn: Gyldendalske Boghandels Forlag.

View

Haffkine WM (1896)
Correspondence: Explanation of his inoculation report forms. Indian Medical Gazette 31:189-190.

View

Winters JE (1896)
Clinical observations upon the use of antitoxin in diphtheria: A report of personal investigation of this treatment in the principal fever hospitals of Europe during the summer of 1895. Medical Record 49:877-893.

View

Heiberg P (1897)
Studier over den statistiske undersøgelsesmetode som hjælpemiddel ved terapeutiske undersøgelser [Studies on the statistical study design as an aid in therapeutic trials]. Bibliotek for Læger 89:1-40.

View

Fibiger J (1898)
Om serumbehandling af difteri [On treatment of diphtheria with serum]. Hospitalstidende 6:309-325.

View

Anonymous (1899)
Echoes and news: the chlorine treatment of diphtheria. Medical News 74:403.

View

Clemow (1899)
Yersin serum treatment of plague. BMJ 1:48.

View

Williams FH (1899)
Scarlatina. Reports of societies. Boston Medical And Surgical Journal 141:348.

View

Cotton FJ (1899)
The Present Status of the Antistreptococcic Serum. New England Journal of Medicine 140:105-109. DOI: 10.1056/NEJM189902021400501

View

Haffkine WM (1900)
On preventive inoculation. Proceedings of the Royal Society of London 65:252-271.

View

Celli A (1900)
The new prophylaxis against malaria in Lazio. Lancet 156; 4031:1603-1606.

View

Celli A (1900)
La nuova profilassi della malaria nel Lazio [The new prophylaxis against malaria in Lazio]. Supplemento al Policlinico 6:1601-1606.

View

Choksy NH (1900)
Professor Lustig’s plague serum. Lancet 2:291-292.

View

Maitland CB (1900)
Methylene blue in malarial fever. BMJ 2:532-533.

View

Park WH (1900)
Use of diphtheria antitoxin in the treatment and prevention of diphtheria. JAMA 34: 902-904.

View

Park WH (1900)
The quantity of diphtheria antitoxin required in the treatment of diphtheria. Archives of Paediatrics 17:823-827.

View

Koch R (1900)
Vierter Bericht über die Thätigkeit der Malaria-Expedition, die Monate März und April 1900 umfassend [Fourth report on the activity of the Malaria Expedition, comprising the months of March and April 1900] Deutsche medicinische Wochenschrift 25:397-398.

View

Lustig A, Galeotti G (1901)
The prophylactic and curative treatment of plague. BMJ 1:206-208.

View

Choksy NH (1901)
Plague treatment with Lustig’s serum. Indian Medical Gazette 36:154–155.

View

Indian Plague Commission (1902)
Serum therapeutics. Investigations conducted by the commissioners. BMJ 1:1159-1160.

View

Gorgas WC (1902)
Mosquito work in Havana. New York: William Wood and Company.

View

Fehling H (1903)
Zur Prophylaxe und Therapie des Puerperalfiebers [On the prophylaxis and treatment of puerperal fever]. Muenchener Medizinische Wochenschrift, 18 Aug.

View

Polverini G (1903)
Serumtherapie gegen Beulenpest Muenchener Medizinische Wochenschrift 50:649-651.

View

Waters EE (1903)
Malaria as seen in the Andamans penal settlement. Lancet 1:1657-62.

View

Celli A (1903)
La malaria in Italia durante il 1902. Parte II: Profilassi della malaria. [Malaria in Italy in 1902. Part II: Prophylaxis of Malaria]. Annali di Igiene Sperimentale 13:322-343.

View

Pearson K (1904)
Report on certain enteric fever inoculation statistics. BMJ 3:1243-1246.

View

Bannerman WB (1905)
Introduction. In: Serum-therapy of plague in India. Scientific Memoirs by Officers of the Medical and Sanitary Departments of the Government of India. Calcutta, India: Office of the Superintendent of Government Printing, pp 1-27.

View

Cousin M (1905)
Des éruptions consecutives aux injections de sérum antidiphthérique et de leur traitement prophylactique par l’ingestion de clorure de calcium. Thèse pour le Doctorat en médicine. Paris : Jules Rousset, 36-44.

View

Haffkine WM, West WG (1905)
Report on a series of 70 cases of plague treated with Brazil’s anti-plague serum. In: Bannerman WB, ed. Serum-therapy of plague in India. Scientific Memoirs by Officers of the Medical and Sanitary Departments of the Government of India. Calcutta, India: Office of the Superintendent of Government Printing, pp 47-59.

View

Haffkine WM (1905)
Report on a series of 484 cases of plague treated with Lustig’s anti-plague serum. In: Bannerman WB, ed. Serum-therapy of plague in India. Scientific Memoirs by Officers of the Medical and Sanitary Departments of the Government of India. Calcutta, India: Office of the Superintendent of Government Printing, pp 27-36.

View

Haffkine WM, Costello CT (1905)
Report on a series of 110 cases of plague treated with Terni’s anti-plague serum. In: Bannerman WB, ed. Serum-therapy of plague in India. Scientific Memoirs by Officers of the Medical and Sanitary Departments of the Government of India. Calcutta, India: Office of the Superintendent of Government Printing, pp 37-46.

View

Rosenbach O (1905)
Die Diagnose als ätiologischer Factor [The diagnosis as a factor in aetiology]. Zeitschrift fur klinische Medicin 56:232-240.

View

West WG (1905)
Report on a series of 68 cases of plague treated with Roux’ anti-plague serum. In: Bannerman WB, ed. Serum-therapy of plague in India. Scientific Memoirs by Officers of the Medical and Sanitary Departments of the Government of India. Calcutta, India: Office of the Superintendent of Government Printing, pp 60-7

View

Netter A (1906)
Efficacité de l’ingestion de chlorure de calcium comme moyen préventif des éruptions consecutives aux injections de sérum [Effect of the ingestion of calcium chloride for preventing eruptions following serum injections]. Séances et Mémoires de la Société de Biologie 58:279-280.

View

Drake DJ (1907)
The treatment of dysentery by yellow santonine. Journal of Tropical Medicine and Hygiene 10:351-352.

View

Goldberger J (1907)
Typhoid "bacillus carriers". In: Rosenau MJ, Lumsden LL, Kastle JH. Report on the origin and prevalence of typhoid fever in the District of Columbia. Hygienic Laboratory, Bulletin No 35, pp 167-174.

View

Choksy NH (1908)
On recent progress in serum-therapy of plague. BMJ 1:1282-1284.

View

Gewin J (1908)
Chlorkalzium gegen die Serumkrankheit [Calcium chloride against serum sickness]. Muenchener Medizinische Wochenshcrift 50:2670-2671.

View

Anonymous (1908)
Alcohol in the treatment of pneumonia and enteric fever. Lancet 157:442.

View

Alt K (1909)
Behandlungsversuche mit Arsenophenylglyzin bei Paralytikern [Treatment experiments with arsenophenylglycine in paralytics]. Muenchener Medizinische Wochenschrift 56:1457-1459.

View

Döderlein D (1910)
The origin and prevention of puerperal fever. BMJ 2:1222-24.

View

Freeman J (1910)
Vaccine therapy. Proceedings of the Royal Society of Medicine 3:97-101.

View

Wechselmann W (1910)
Über die Behandlung der Syphilis mit Dioxydiamido-arseno-benzol [On the treatment of syphilis with dioxy-diamido-arseno-benzol]. Berliner Klinische Wochenschrift 47:1261-1264.

View

Solis-Cohen M, Strickler A (1911)
The effect produced by some therapeutic measures on the different forms of leucocytes in pulmonary tuberculosis. New England Journal of Medicine 165:563-568.

View

Advisory Committee on Plague Investigations in India (1912)
The serum treatment of human plague. Journal of Hygiene. Plague Supplement II, LVI:326-39.

View

Freeman RG (1912)
Serum treatment of pneumonia. JAMA 59:140.

View

McDonagh JER (1912)
Salvarsan in syphilis and allied diseases. Oxford: Oxford Medical Publications.

View

Park WH (1912)
The role of animal experimentation in the discoveries leading to our present knowledge of the etiology, prevention and cure of diphtheria. JAMA 53:453-459.

View

De Quervain JF (1913)
Die Behandlung der akute Appendicitis auf Grund einer schweizerischen Sammelstatistik [The treatment of acute appendicitis on the basis of aggregated Swiss hospital statistics]. Correspondenzblatt für Schweizer Aerzte 43:1609-1624.

View

Rosenow EC, Hektoen L (1913)
Treatment of pneumonia with partially autolyzed pneumococci. JAMA 61:2203-4.

View

Council on Pharmacy and Chemistry (1913)
Sinkina. JAMA 61:1056-1058.

View

Carver AE (1914)
Pneumosan in the treatment of pulmonary tuberculosis. Lancet 2:372-373.

View

Wright AE (1914)
On pharmaco-therapy and preventive inoculation applied to pneumonia in the African Native. London: Constable, p 84.

View

Wright AE, Morgan WP, Colebrook L, Dodgson RW (1914)
Observations on prophylactic inoculation against pneumococcus infections, and on the results which have been achieved by it. Lancet 1:87-95

View

Goadby K (1916)
An inquiry into the natural history of septic wounds. Lancet 188: 89-95.

View

Leake JP (1917)
Bacterial vaccine therapy. JAMA 69:631-632.

View

Von Sholly AI, Blum J, Smith L (1917)
The therapeutic value of pertussis vaccine in whooping cough. JAMA 68:1451-1456.

View

Avata AA, Woodyatt RT (1918)
Treatment of facial erysipelas at Camp Cody, N.M. JAMA 71:900-01.

View

Bingel A (1918)
Über Behandlung der Diphtherie mit gewöhnlichem Pferdeserum [On the treatment of diphtheria with normal horse serum]. Deutsches Archiv für Klinische Medizin 125:284-332.

View

Kyes P (1918)
The treatment of lobar pneumonia with an anti-pneumococcus serum. Journal of Medical Research 38:495-501.

View

McCoy GW, Murray VB, Teeter AL (1918)
The failure of a bacterial vaccine as a prophylactic against influenza. JAMA 71:1997.

View

Lees D (1919)
Detoxicated vaccines in the treatment of gonorrhœa: the value of the complement-deviation test in controlling the treatment and estimating its therapeutic effect. Lancet 1:1107-1111.

View

Leighton Kesteven H (1919)
A study of epidemic influenza in Australia. Lancet 2:1189-91.

View

Pearl R (1919)
A statistical discussion of the relative efficacy of different methods of treating pneumonia. Archives of Internal Medicine 24:398-403.

View

Mcguire LW, Redden WR (1919)
Treatment of Influenzal pneumonia by the use of convalescent human serum, Second report. JAMA 72:709-713. doi:10.1001/jama.1919.02610100017007

View

Gray AW (1920)
Antipneumococcus serum (Kyes’s) in the treatment of pneumonia. American Journal of Medical Sciences 159:885-891.

View

Acton HW (1920)
Researches on the treatment of benign tertian fever. Lancet 1:1257-1261.

View

Cecil RL, Larsen NP (1922)
Clinical and bacteriologic study of one thousand cases of lobar pneumonia. JAMA 79:343-349.

View

Johnston RA, Siddall RS (1922)
Is the usual method of preparing patients for delivery beneficial or necessary? American Journal of Obstetrics and Gynecology 4:645-650.

View

Kopeloff N, Kirby GH (1923)
Focal infection and mental disease. American Journal of Psychiatry 3:149-197.

View

Greenwood M (1924)
Is the statistical method of any value in medical research? Lancet 2: 153-158.

View

Locke EA (1924)
The serologic treatment of lobar pneumonia. Boston Medical and Surgical Journal 190:196-203.

View

Diehl HS (1925)
Value of Chlorin in the treatment of colds. JAMA 84:1629-32.

View

Fletcher W (1925)
The relative efficiency of quinine and quinidine in the treatment of malaria. In: Medical Research Council. Clinical comparisons of quinine and quinidine. London: Her Majesty's Stationery Office, pp 17-27.

View

Lewis S (1925)
Arrowsmith. New York: Collier.

View

Malaria Commission of the Health Organisation (1925)
Report on its tour of investigation in certain European countries in 1924. Geneva: League of Nations. C.H. 273.

View

Oliver WW, Stoller EA (1925)
Notes on the therapeutic value of pneumococcus antibody solution subcutaneously administered in lobar pneumonia. Archives of Internal Medicine 35:267-286.

View

Park WH (1925)
Scarlet fever: etiology, prevention by immunization, and antitoxic treatment. JAMA 85:1180-1186.

View

Medical Research Council (1925)
Report of the committee upon cinchona derivatives and malaria. In: Clinical comparisons of quinine and quinidine. London: HMSO, pp 5-16.

View

Swellengrebel NH (1925)
A summary of the more important facts on adult anophelines and their larvae observed by us or brought to our notice duing our tour through eastern Europe and Italy (May-September 1924). pp183-190. In: Malaria Commission of the Health Organisation (1925). Report on its tour of investigation in certain European countries in 1924. Geneva: League of Nations. C.H. 273.

View

Mauel W (1926)
Ist das Omnadin bei kruppöser Pneumonie wirksam [Is Omnadin effective in pneumonia with croup]? Münchener Medizinische Wochenschrift 73:652.

View

Wagner-Jauregg J (1926)
Die moderne Therapie der Neurolues [On modern therapy for neurosyphilis]. Verhandlungen der Deutschen Gesellschaft für Innere Medizin. Achtundreissigster Kongress. München: Bergmann, p 34-62.

View

Sinton JA (1926)
Studies in Malaria, with special reference to Treatment. Part I. Introduction and routine methods. Indian Journal of Medical Research 13: 565-577.

View

Sinton JA (1926)
Studies in Malaria, with special reference to treatment. Part II. The effects of treatment on the prevention of relapse in infections with Plasmodium Falciparum. Indian Journal of Medical Research 13: 579-601.

View

Ferguson FR, Davey AFC, Topley WWC (1927)
The value of mixed vaccines in the prevention of the common cold. Journal of Hygiene 26:98-109.

View

Gordon E (1927)
Treatment of scarlet fever with streptococcus antitoxin. JAMA 88:382-5.

View

Harries (1927)
Discussion on the serum treatment of scarlet fever. Proceedings of Royal Society of Medicine 20:1175–1176.

View

Symmers D, Lewis KM (1927)
The antitoxin treatment of erysipelas: observations in one hundred and thirty-one patients at Bellevue Hospital. JAMA 89:880-2.

View

Sinton JA (1927)
Studies in Malaria, with special reference to treatment. Part VII. The intravenous injection of sodium stovarsol in the treatment of benign tertian malaria. Indian Journal of Medical Research 15:287-299.

View

Bullowa JGM (1928)
Use of antipneumococcic refined serum in lobar pneumonia: data necessary for a comparison between cases treated with serum and cases not so treated, and the importance of a significant control series of cases. JAMA 90: 1354-1358.

View

Bullowa JGM (1928)
The control. Contribution to a symposium on the use of antipneumococcic refined serum in lobar pneumonia, 15 December 1927. Bulletin of the New York Academy of Sciences 4:339-343.

View

Cecil RL, Sutliff WD (1928)
The treatment of lobar pneumonia with concentrated anti-pneumococcus serum. JAMA 91:2036-2040.

View

Cecil RL (1928)
Specific treatment of lobar pneumonia. Archives of Internal Medicine 41:295-335.

View

Ferry NS, Gordon EJ, Munro FW, Steele AH, Fisher LW (1928)
Clinical results with measles streptococcus toxin and antitoxin. JAMA 91:1277-1280.

View

McCann WS (1928)
The serum treatment of erysipelas. JAMA 91:78-81.

View

Park WH, Bullowa JGM, Rosenbluth NM (1928)
The treatment of lobar pneumonia with refined specific antibacterial serum. JAMA 91:1503-1508.

View

Ross WC, Bagchi KN , Roy BC (1928)
The bacteriophage in cholera. Indian Journal of Medical Research 15:965-968.

View

Bullowa JGM (1929)
The serum treatment and its evaluation in lobar pneumonia. Bulletin of the New York Academy of Medicine 5:328-362.

View

Joe A, Swyer R (1929)
A study of passive immunisation in scarlet fever. Lancet 1:177-179.

View

Pearce RM (1929)
The treatment of influenza with S.U.P. 36. BMJ 2:663-666.

View

Sinton JA, Bird W (1929)
Studies in Malaria, with special reference to treatment. Part XI: The Cinchona alkaloids in the treatment of benign tertian malaria. Indian Journal of Medical Research 16: 725-746.

View

Benson WT (1930)
The treatment of erysipelas with vaccines. Lancet 2:1286-289.

View

Cecil RL, Plummer N (1930)
Pneumococcus type I pneumonia - a study of eleven hundred and sixty-one cases, with especial reference to specific therapy. JAMA 95:1547-1553.

View

Finland M (1930)
The serum treatment of lobar pneumonia. New England Journal of Medicine 202:1244-1247.

View

Iversen P (1930)
Nogle bemærkninger om komplikationerne til parotitis epidemica og forsøg paa behandling med rekonvalescentserum [Treatment of complications of epidemic mumps with the serum of convalescents]. Ugeskrift for Læger 92:167-169.

View

Kauders O (1930)
Ueber Nachbehandlung nach Malariatherapie [On the management of patients after malaria therapy]. Deutsche Medizinishe Wochenshcrift 61:400-401.

View

Physicians to the Royal Infirmary, Edinburgh (1930)
A report on lobar pneumonia: treatment by concentrated antiserum. Lancet 2:1390-1394.

View

Wyckoff J, Du Bois EF, Woodruff IO (1930)
The therapeutic value of digitalis in pneumonia. JAMA 95:1243-1249.

View

Amberson JB, McMahon BT, Pinner M (1931)
A clinical trial of sanocrysin in pulmonary tuberculosis. American Review of Tuberculosis 24:401-435.

View

Doull JA, Hardy M, Clark JH, Herman NB (1931)
The effect of irradiation with ultra-violet light on the frequency of attacks of upper respiratory disease (common colds). American Journal of Hygiene 13:460-77.

View

Friend GE (1931)
Amidopyrin in measles. BMJ 1:33.

View

Green HN, Pindar D, Davis G, Mellanby E (1931)
Diet as a prophylactic agent against puerperal sepsis. BMJ 2:595-598.

View

Koenigsberger E (1931)
Die Behandlung der malignen Diphtherie, nach Erfahrungen in Berlin und Kopenhagen [Treatment of malignant diphtheria based on experiences in Berlin and Copenhagen]. Deutsche Medizinische Wochenschrift 57:842-845.

View

Manson-Bahr P (1931)
Modern methods of treatment of intestinal amœbiasis. Proceedings of Royal Society of Medicine 24:1538–1548.

View

Naidu BPB, Mackie FP (1931)
The serum therapy of plague. Lancet 2:893-897.

View

Roos H (1931)
Behandling av kruppös pneumoni med kininjektioner [Treatment of acute pneumonia with quinine injections]. Finska Läkaresällskapets Handlingar 73:778-789.

View

Sutliff WD, Finland M (1931)
Type I lobar pneumonia treated with concentrated pneumococcic antibody (Felton). The clinical course. JAMA 96:1465-1469.

View

Swyer R (1931)
Antigenic properties of diphtheria toxoid-antitoxin floccules. Lancet 1:632-634.

View

Wagner-Jauregg J (1931)
Ueber die Infektionsbehandlung der progressiven Paralyse [On infection treatment of progressive paralysis]. Münchener Medizinische Wochenschrift 78:4-7.

View

Armstrong RR, Johnson RS (1932)
Treatment of lobar pneumonia by anti-pneumococcal serum. BMJ 2:662-65.

View

Blatt ML, Shaw NG (1932)
Bacillary dysentery in children: a report of the cases in the Cook County Children's Hospital, Chicago, for 1932. Presented a Regular Meeting of the Chicago Pediatric Society, 20 Dec 1932, reported in Archives of Pediatrics.

View

Cecil RL, Plummer N (1932)
Pneumococcus Type II pneumonia: a clinical and bacteriologic study of one thousand cases, with especial reference to serum therapy. JAMA 98:779-86.

View

Ellison JB (1932)
Intensive vitamin therapy in measles. BMJ 2:708-711.

View

Riding D, Corkhill NL (1932)
Prophylactic vaccination in epidemic meningococcal meningitis. Journal of Hygiene 32:258-267.

View

Sanders JP, Dawson, WT (1932)
Efficacy of quinidine in malaria. JAMA 99:1773-7.

View

Borovsky MP, Steigmann F (1933)
Amidopyrine in the treatment of measles. JAMA 100:1859-61.

View

Diehl HS (1933)
Medicinal treatment of the common cold. JAMA 101:2042-2049.

View

Hottinger A, Toepfer D (1933)
Über den Wert der Serumtherapie bei Diphtherie, insbesondere bei der malignen, toxischen form [On the value of serum therapy of diphtheria, particularly in its malignant, toxic form]. Zeitschrifte für Kinderheilkunde 54:505-529.

View

Kessel JF, Rose EJ (1933)
Bacteriophage Therapy in Bacillary Dysentery of the Flexner Type*†. Annals of Internal Medicine 6:1193-1199.

View

Macnamara J (1933)
Serum therapy in poliomyelitis. BMJ 1:526-8.

View

Sutliff WD, Finland M, Hunnicutt TN (1933)
Direct comparison between specific and nonspecific serum therapy for type 1 lobar pneumonia. Archives of Internal Medicine 51:435-446.

View

Bullowa JGM (1934)
Therapeutic pneumococcus Type VIII (Cooper) serum. JAMA 102: 1560-1561.

View

Field JW (1934)
The substitution of atebrin for quinine in treated “ambulatory” cases of malaria on rubber estates. In: Neave Kingsbury A. Annual Report of the Institute for Medical Research, Federated Malay States, p 16-24.

View

Medical Research Council Therapeutic Trials Committee (1934)
The serum treatment of lobar pneumonia. BMJ 1:241-245.

View

Fischer A (1934)
Human Convalescent Serum in the Treatment of Preparalytic Poliomyelitis. Am J Dis Child 48: 481-501.

View

Kalke M (1935)
Hikoilukuurin vaikutuksesta influensan kulkuun ja sen leviämisestä eri paikkakunnilta saapuneiden asevelvollisten keskuuessa VJP:ssä v.1933. [The effect of a sweating cure on the course of influenza and its transmission among conscripts from different localities joining the Vuoksi Jaeger Battalion in 1933.] Sotilaslääketieteellinen Aikakauslehti, s28-34.

View

McSweeny CJ (1935)
Clinical trials with a new antityphoid serum. Lancet 1:1095-1098.

View

Robin L, Van-Huan T (1935)
Essais comparés de prophylaxie médicamenteuse en région hyperendémique par la praequine et la quinine ou la quinacrine [Comparative trials of anti-malarial drug prophylaxis in a hyperendemic area with præquine, associated with quinine or quinacrine]. Bulletin de la Société de Pathologie exotique 28:650-658.

View

Wetherbee W, Foley JA, Resnik J (1935)
Diathermy in pneumonia – preliminary report. New England Journal of Medicine 213:796-8.

View

Hicks EP, Diwan Chand S (1935)
The relative clinical efficacy of totaquina and quinine. In: Records of the Malaria Survey of India 5:39-50.

View

Begg N, Coveney MF (1936)
Whooping-cough: value of a specific vaccine in treatment. Lancet 1:82-83.

View

Colebrook L, Kenny M (1936)
Treatment of human puerperal infections, and of experimental infections in mice, with prontosil. Lancet 1:1279-1286.

View

Colebrook L, Kenny M (1936)
Treatment with prontosil of puerperal infections due to haemolytic streptococci. Lancet 2:1319-1322.

View

Curphey TJ, Solomon S (1936)
The therapeutic value of calcium salts in serum sickness. New England Journal of Medicine 214:150-153.

View

Doull JA, Shibley GS, McClelland JE (1936)
Active immunization against whooping cough: interim report of the Cleveland experience. American Journal of Public Health 26:1097-1105.

View

Gilliam AG, Onstott RH (1936)
Results of field studies with poliomyelitis vaccine. American Journal of Public Health 26:113-118.

View

Hoyne AL (1936)
Intravenous treatment of meningococcic meningitis with Meningococcus antitoxin. JAMA 107:478-81.

View

Pasricha CL, de Monte AJH, O’Flynn EG (1936)
Bacteriophage in the treatment of cholera. Indian Medical Gazette 71:61-68.

View

Sutliff WD (1936)
Adequate tests of curative therapy in man. Annals of Internal Medicine 1936-1937;10:89-97.

View

Bastianelli G, Mosna E, Canalis A (1937)
Prevention and treatment of malaria by synthetic drugs. Bulletin of the Health Organisation of the League of Nations 6:822-891.

View

Bullowa JGM (1937)
Serum therapy. In: Bullowa JGM. The management of the pneumonias. New York: Oxford University Press, pp 283-298.

View

Colebrook L, Purdie AW (1937)
Treatment of 106 cases of puerperal fever by sulphanilamide. Lancet 2:1237-1242 & 1291-1294.

View

Cookson H, Facey RV (1937)
Value of a specific serum in the treatment of typhoid fever. BMJ 1:1009-1012.

View

Cunningham AA (1937)
Vaccine treatment of measles. BMJ 1:1202-1203.

View

Field JW, Niven JC, Hodgkin EP (1937)
The prevention of malaria in the field by the use of quinine and atebrine. Bulletin of the Health Organisation of the League of Nations 6:236-290.

View

Hesseltine HC (1937)
Evaluation by controlled series of vaginal trichomoniasis therapies. JAMA 109:768-71.

View

Hill AB (1937)
Artificial pneumothorax on statistical trial. Lancet 229: 535-536.

View

Hogarth JC (1937)
Para-benzylaminobenzene-sulphonamide in the treatment of scarlet fever. BMJ 2:1160-1162.

View

Parrot A, Catanei A, Ambialet R, Clastrier J (1937)
Comparative experiments in mass prophylaxis of malaria by means of quinine and synthetic drugs (quinacrine and praequine). Bulletin of the Health Organization of the League of Nations 6:685-765.

View

Peters BA, Cullum IM (1937)
Post-scarlatinal nephritis: a study in prevention. BMJ 1:1020-21.

View

Peters BA, Havard RV (1937)
Chemotherapy of streptococcal infections with p-bezylamino-benzene-sulphonamide. Lancet 1:1273-4.

View

Snodgrass WR, Anderson T (1937)
Prontosil in the treatment of erysipelas: a controlled series of 312 cases. BMJ 2:101-104.

View

Snodgrass WR, Anderson T (1937)
Sulphanilamide in the treatment of erysipelas: a controlled series of 270 cases. BMJ 2:1156-9.

View

Malaria Commission (1937)
The treatment of Malaria: Study of synthetic drugs, as compared with Quinine, in the therapeutics and prophylaxis of Malaria. Bulletin of the Health Organisation, Vol VI, no. 6.

View

Diehl HS, Baker AB, Cowan DW (1938)
Cold vaccines: an evaluation based on a controlled study. Journal of American Medical Association 111:1168-1173.

View

Evans GM, Gaisford WF (1938)
Treatment of pneumonia with 2-(p-aminobenzene sulphonamido) pyridine. Lancet 2:14-19.

View

Gaudin HJ, Zide HA, Thompson GJ (1938)
Use of sulfanilamide after transurethral prostatectomy. JAMA 110:1887-90.

View

Harrison WT, Franklin JP, Bell JA (1938)
Prophylactic value of a single dose of precipitated pertussis vaccine. Public Health Reports 53:793-796.

View

Johnstone RW (1938)
Prophylactic use of sulphonamide preparations in obstetric practice. BMJ 1:562-64.

View

Lash AF (1938)
Concentrated streptococcus (hemolytic) antitoxic serum in puerperal fever: further therapeutic studies. JAMA 110:1988-91.

View

Nissen NI (1938)
Erfahrungen mit der Serumtherapie der kruppösen Pneumonie. [Experiences with serum therapy of pneumonia with croup]. Deutsche Medizinische Wochenschrift 64:221-225.

View

Orenstein AJ (1938)
Report for the year 1937. Health Department, Central Mining-Rand Mines Group, p 8.

View

Peters BA (1938)
A comparative test of natural and concentrated anti-toxin in treatment of malignant diphtheria. BMJ 2:344-346.

View

Schwentker FF, Waghelstein J (1938)
A note on the use of sulfanilamide in scarlet fever. Baltimore Health News 15:41-44.

View

Snodgrass WR, Anderson T, Rennie JL (1938)
Sulphamido-chrysoidine, sulphanilamide, and benzylsulphanilamide in the treatment of erysipelas. BMJ 2:399-403.

View

Bowie FJ (1938)
Chemotherapy in gonorrhoea: a preliminary report on the use of 2-(p-aminobenzenesulphonamido)pyridine, M & B 693. BMJ 2:283-284.

View

Anderson T (1939)
Sulphanilamide in the treatment of measles. BMJ 1:716-718.

View

Banks HS (1939)
Chemotherapy of meningococcal meningitis. Lancet 2:921-927.

View

Benn EC (1939)
Sulphanilamide in the treatment of scarlet fever. BMJ 2:644-646.

View

Cutts M, Gormly CF, Burgess AM (1939)
The treatment of lobar pneumonia with sulfapyridine. New England Journal of Medicine 221:263-266.

View

Farnworth Anderson T, Dowdeswell RM (1939)
Treatment of pneumonia with M. & B. 693. Lancet 1:252-255.

View

Graham D, Warner WP, Dauphinée JA, Dickson RC (1939)
The treatment of pneumococcal pneumonia with Dagenan (M&B 693). Canadian Medical Association Journal 40:325-332.

View

Kendrick P, Eldering G (1939)
A study in active immunization against pertussis. American Journal of Hygiene 29 Sec. B:133-153.

View

Lanman TH, Heyl HL (1939)
Empyema in Children. New England Journal of Medicine 221:1003-1009.

View

Pasricha CL, de Monte AJH, Chatterjee BC, Mian AS (1939)
Treatment of cholera (A note on the results of treatment by different methods). Indian Medical Gazette 74:400-401.

View

Price AE, Myers GB (1939)
Treatment of pneumococcic pneumonia with sulfanilamide. JAMA 112:1021-7.

View

Top FH, Young DC (1939)
Specific and non-specific serum treatment of scarlet fever. American Journal of Public Health 29:443-451.

View

Volini IF, Levitt RO (1939)
The treatment of Pneumococcic pneumonia with concentrated rabbit serum. JAMA 113: 1314-6.

View

Don CSD, Luxton RW, Donald HR, Ramsay WA, Macartney DW, Stewart Smith G, Adderley CH (1940)
Treatment of pneumonia with M&B 693. Lancet 1:311-4.

View

Gaisford WF, Whitelaw W (1940)
Sulphathiazole in treatment of pneumococcal lobar pneumonia. Lancet 2:451-452.

View

Gregory KK, West EJ, Stevens RE (1940)
Epidemic cerebrospinal meningitis (meningococcic): the treatment of 113 patients with antimeningococcus serum, meningococcus antitoxin and sulfanilamide. JAMA 115:1091-5.

View

Jordan JH, Blakelock, Johnston WR (1940)
Treatment of cerebrospinal fever with suphapyridine. BMJ 1:1005-1008.

View

Menten ML, Macdonald RR, Brönykovsky N (1940)
Treatment of pneumonia by sulfapyridine and by hydroxyethylapocupreine dihydrochloride. American Journal of Diseases of Children 59:497-508.

View

Rhoads PS, Afremow ML (1940)
Sulfanilamide in treatment of sore throat due to hemolytic streptococci: with controls. JAMA 114:942-3.

View

Abraham EP, Chain E, Fletcher CM, Gardner AD, Heatley NG, Jennings AM, Florey HW (1941)
Further observations on penicillin. Lancet 2:177-189.

View

Anderson DEW, Cruickshank R (1941)
The treatment of bacilliary (Flexner) dysentery with sulphanilylguanidine. BMJ 2:497-501.

View

Bell JA (1941)
Pertussis prophylaxis with two doses of alum-precipitated vaccine. Public Health Reports 56:1535-1546.

View

Cooper ML, Zucker RL, Wagoner S, Brown EW, Bennett R (1941)
Sulfathiazole for acute diarrhea and dysentery of infants and children. JAMA 117:1520-3.

View

Ewalt JR, Ebaugh FG (1941)
Treatment of dementia paralytica: A five year comparative study of artificial fever therapy and therapeutic malaria in two hundred and thirty-two cases. JAMA 116:2474-77.

View

Fleming JB (1941)
Treatment of diphtheria. BMJ 1:907.

View

Jones HB, Fairbrother RW (1941)
Sulphathiazole and sulphapyridine in acute gonorrhoea. Lancet 2:9-10.

View

Kaufman P (1941)
Studies on old age pneumonia. II. Prophylactic effect of pneumococcus polysaccharide against pneumonia. Archives of Internal Medicine 61:304-319.

View

Plummer N, Liebmann J, Solomon S, Kammerer WH, Kalkstein M, Ensworth HK (1941)
Chemotherapy versus combined chemotherapy and serum. JAMA 116:2366-2371.

View

Top FH, Young DC (1941)
The treatment of moderately severe scarlet fever: A study of alternate patients treated with sulfanilamide, convalescent serum and scarlet fever antitoxin. JAMA 117:2056-60.

View

Wagle PM, Sokhey SH, Dikshit BB, Ganapathy K (1941)
Chemotherapy in plague. Indian Medical Gazette 76:29-32.

View

Kendrick PL (1942)
Use of alum-treated pertussis vaccine, and alum-precipitated combined pertussis vaccine and diphtheria toxoid, for active immunization. American Journal of Public Health 32:615-626.

View

Lipman Cohen E (1942)
Local treatment of impetigo with sulphonamide. BMJ 1:359.

View

Siegel M (1942)
Studies on the control of acute respiratory infections: preliminary report on the oral administration of sulfadiazine at the onset of acute respiratory illnesses. JAMA 119:783-5.

View

Florey ME, Florey HW (1943)
General and local administration of penicillin. Lancet 1:387.

View

Hopkins WA (1943)
Patulin in the common cold. IV: Biological properties: extended trial in the common cold. Lancet 2:630-635.

View

Kendrick PL (1943)
Field study of alum-precipitated combined pertussis vaccine and diphtheria toxoid for active immunization. American Journal of Hygiene 38:193-202.

View

Lepper MH, Sweet LK, Dowling HF (1943)
The treatment of meningococcic infections with sulphadiazine and sulphamerazine. JAMA 123:134-138.

View

Morgan TN, Wylie-Smith R (1943)
Lobar pneumonia treated with sulphamezathine and sulphadiazine. Lancet 2:731-733.

View

Pulvertaft RJPV (1943)
Local therapy of war wounds: I with Penicillin (article 1 of 2). Lancet 2:341-36 and 379-384

View

Stuart-Harris CH, Francis AE, Stansfeld JM (1943)
Patulin in the common cold. Lancet 2:684.

View

Greenwood M (1943)
Statistical note. Lancet 2:634-5.

View

Beattie J, Marshall J (1944)
Studies on hepatic dysfunction. II. The value of sulphur-containing amino-acids and casein digest in the prevention of post-arsphenamine jaundice. BMJ 2: 651-655.

View

Boyd JSK, Portnoy B (1944)
Bacteriophage therapy in bacillary dysentery. Transactions of the Royal Society of Tropical Medicine and Hygiene 37:243-262.

View

Cecil RL, Plummer N, Smillie WG (1944)
Sulfadiazine in the treatment of the common cold. JAMA 124:8-14.

View

Coburn AF (1944)
The prevention of respiratory tract bacterial infections. JAMA 126:88-89.

View

Commission on Influenza (1944)
A clinical evaluation of vaccination against influenza. JAMA 124:982-985.

View

Cutler EC (1944)
Discussion on Penicillin. Proceedings of Royal Society of Medicine 37: 101–12.

View

Dick A (1944)
Vaccines and chemotherapy in pneumococcal lobar pneumonia. Lancet 1:564-565.

View

Florey ME, Williams REO (1944)
Hand infections treated with penicillin. Lancet 1:73-81.

View

Fries ED (1944)
The treatment of tonsillitis with small doses of sulfonamides. JAMA 126:93-4.

View

Hinshaw HC, Feldman WH (1944)
Evaluation of therapeutic agents in clinical tuberculosis. American Review in Tuberculosis 50:202-213.

View

Medical Research Council (1944)
Clinical trial of patulin in the common cold. Lancet 2:373-5.

View

Scadding JG (1944)
Comparative effects of sulphonamide drugs in mild bacillary dysentery. Lancet 1:784-786.

View

Stansfeld JM, Francis AE, Stuart-Harris CH (1944)
Laboratory and clinical trials of Patulin. Lancet 2:370-372.

View

Wolman M (1944)
Treatment of typhus with anti-typhus horse serum. Lancet 2:210-12.

View

Wright J, Cruickshank R, Gunn W (1944)
The control of dust-borne streptococcal infection in measles wards. BMJ 1:611-614.

View

Yeomans A, Snyder JC, Murray ES, Zarafonetis CJD, Ecke RS (1944)
The therapeutic efficacy of para-aminobenzoic acid in louse borne typhus fever. JAMA 126:349-56.

View

Mackenna RMB, Cooper-Willis ES (1945)
Impetigo contagiosa in the army, treated with microcrystalline sulphathiazole. Lancet 2:357-358.

View

Anderson T, Ferguson MS (1945)
Comparative effect of sulphonamide and penicillin in pneumonia. Lancet 2:805-808.

View

Bahlke AM, Perkins JE (1945)
Gamma globulin in poliomyelitis. JAMA 129:1146-1150.

View

Darmady EM (1945)
The effects of protein diet on infective hepatitis. BMJ 1:795-797.

View

Fletcher RT, Scadding JG (1945)
Observations on the MI room treatment of “acute simple diarrhoea” with sulphaguanidine. Unpublished manuscript.

View

Gellis SS, Stokes J, Forster HW, Brother GM, Hall WM (1945)
The use of human immune serum globulin (gamma globulin) in infectious (epidemic) hepatitis in the Mediterranean theater of operations II. Studies on treatment in an epidemic of infectious hepatitis. JAMA 128:1158-9.

View

Grossman EB, Stewart SG, Stokes J (1945)
Post-transfusion hepatitis in battle casualties: and a study of its prophylaxis by means of human immune serum globulin. JAMA 129:991-4.

View

Havens WP, Paul JR (1945)
Prevention of infectious hepatitis with gamma globulin. JAMA 129:270-272.

View

Higgins G, O'Brien JRP, Peters RA, Stewart A, Witts LJ (1945)
Treatment of infectious hepatitis with methionine. BMJ 1:401-402.

View

MacLeod CM, Hodges RG, Heidelberger M, Bernhard WG (1945)
Prevention of pneumococcal pneumonia by immunization with specific capsular polysaccharides. Journal of Experimental Medicine 82:445-465.

View

McFarlan AM, Topley E, Fisher M (1945)
Trial of whooping-cough vaccine in city and residential nursery groups. BMJ 2:205-208.

View

Richardson JS, Suffern WS (1945)
A therapeutic trial of choline chloride in infective hepatitis. BMJ 2:156-157.

View

Rosenthal SR, Blahd M, Leslie EI (1945)
Ten years’ experience with BCG (experimental and clinical). Journal of Pediatrics 26:470-80.

View

Scadding JG (1945)
Sulphonamides in bacillary dysentery. Lancet 2:549-553.

View

Wilson C, Pollock MR, Harris AD (1945)
Therapeutic trial of methionine in infective hepatitis. BMJ 1:399-401.

View

Wolman M, Omar M, Abu-Taimb M (1945)
Louse-borne relapsing fever treated with calcium gold keratinate. Lancet 2:775-777.

View

Wright J (1945)
Cross-infection risks in the hospitalization of measles patients. BMJ 1:285-289.

View

Aronson JD, Palmer CE (1946)
Experience with BCG vaccine in the control of tuberculosis among North American Indians. Public Health Reports 61:802-820.

View

Christie RV (1946)
Penicillin in subacute bacterial endocarditis. Lancet 1:369.

View

Fatti L, Florey ME, Joules H, Humphrey JH, Sakula J (1946)
Acutely infected pleural effusions: techniques of penicillin treatment. Lancet 1:295-300

View

Levine MI, Sackett MF (1946)
Results of BCG vaccination in New York City. American Review of Tuberculosis 53:517-532.

View

Tierney NA (1946)
Effect of para-aminobenzoic acid in Tsutsugamushi disease. JAMA 131:280-5.

View

Wilson C, Pollock MR, Harris AD (1946)
Diet in the treatment of infective hepatitis. Lancet 1:881-883.

View

Johnstone RDC (1946)
Relapsing benign tertian malaria treated with paludrine. Lancet 2:825-826.

View

Anderson T, Landsman JB (1947)
Oral penicillin in treatment of pneumonia in the adult. BMJ 2:950-953.

View

Bolton JH, Pivawer MJ (1947)
Faucial diphtheria among army personnel in Belgium, 1945. BMJ 2:373-376.

View

Furber Murphy A (1947)
Treatment of acute mastitis. BMJ 1:271.

View

Glickman I (1947)
The use of penicillin lozenges in the treatment of Vincent’s infection and other acute gingival inflammations. Journal of the American Dental Association 34:406-409.

View

Hirsh HL, Rotman-Kavka, G, Dowling HF, Sweet LK (1947)
Penicillin therapy of scarlet fever: comparison with antitoxin and symptomatic therapy. JAMA 133:657-61.

View

Mitchell GAG (1947)
The value of penicillin in surgery. BMJ 1:41-45.

View

Bell JA (1948)
The epidemiological principles and procedures involved in a study of the prophylactic value of an alum-precipated mixture of diphtheria toxoid and pertussis vaccine. Thesis submitted to the School of Hygiene and Public Health of the Johns Hopkins University in conformity with the requirements for the Degree of Doctor of Public Health.

View

Bell JA (1948)
Diphtheria immunization use of an alum-precipitated mixture of pertussis vaccine and diphtheria toxoid. JAMA 137:1009-1016.

View

Bell JA (1948)
Pertussis immunization use of two doses of an alum-precipitated mixture of diphtheria toxoid and pertussis vaccine. JAMA 137:1276-1281.

View

Bevan G, Evans R, Pugh I, Sudds MVN, Parker MT, Sladden AFS (1948)
Penicillin and sulphathiazole in typhoid fever: clinical trial. Lancet 1:545-550.

View

Christie RV (1948)
Penicillin in subacute bacterial endocarditis. BMJ 1:1-4.

View

Jersild T (1948)
Penicillin therapy in scarlet fever and complicating otitis. Lancet 1:671-673.

View

Löfström G (1948)
Investigations on acute infections of the respiratory tract. IV. Experimental studies on the effect of small doses of sulphonamides in respiratory tract infections. Acta Medica Scandinavica 130:1-11.

View

Malchow-Møller M (1948)
Sulfathiazol og diazil. [sulphamethazine]. Ugeskrift for Læger 110:466-8.

View

Medical Research Council (1948)
Streptomycin treatment of tuberculous meningitis. Lancet 1:582-596.

View

Medical Research Council (1948)
Streptomycin treatment of pulmonary tuberculosis: a Medical Research Council investigation. BMJ 2:769-782.

View

Mellanby H, Andrewes CH, Dudgeon JA, Mackay DG (1948)
Vaccination against influenza A. Lancet 251:978-982.

View

Parsons CG (1948)
Penicillin and sulphonamides in typhoid fever: experience of physicians in military hospitals in the Middle East. Lancet 1:510-513

View

War Office (1948)
Efficacy of therapeutic measures. In: Statistical Report on the Health of the Army, 1943-1945. London: Her Majesty's Stationary Office, p 273-294.

View

Appelbaum E, Nelson J, Albin MB (1949)
The treatment of penumococcic meningitis with penicillin; a study of 125 consecutive cases, with 73% recovery. American Journal of Medicial Science 218:260-4.

View

Bingel A (1949)
Wirkt das Diphtherieheilserum bei der menschlichen Diphtheriekrankheit spezifisch durch seinen Antitoxingehalt oder unspezifisch [Does curative diphtheria serum act specifically through its anti-toxin content or non-specifically in human diphtheria]? Deutsche Medizische Wochenschrift 74:101-103.

View

Ferguson RG, Simes AB (1949)
BCG vaccination of Indian infants in Saskatchewan. Tubercle 30:5-11 30:5-11.

View

Harrison SH, Topley E, Lennard-Jones J (1949)
The value of systemic penicillin in finger pulp infections: a controlled trial of 169 cases. Lancet 1:425-430.

View

Kaufman P (1949)
Pneumonia in old age: active immunization against pneumonia with pneumococcus polysaccharide results of a six your study. Archives of Internal Medicine 79:518-531.

View

Daniels M (1950)
Scientific appraisement of new drugs in tuberculosis. American Review of Tuberculosis 61:751-756.

View

Downes J (1950)
An experiment in the control of tuberculosis among negroes. Milbank Memorial Fund Quarterly 28:180-220.

View

Jacobs A, Borthwick WM (1950)
Streptomycin in urinary tuberculosis. Proceedings of the Royal Society of Medicine 43:453-466.

View

Long ER, Ferebee SH (1950)
A controlled investigation of streptomycin treatment in tuberculosis. Public Health Reports 65:1421-1451.

View

Medical Research Council (1950)
Clinical trials of antihistaminic drugs in the prevention and treatment of the common cold. BMJ 2:425-431.

View

Swedish National Association against Tuberculosis. Therapeutic Trials Committee (1950)
Para-aminosalicylic acid treatment in pulmonary tuberculosis. American Review of Tuberculosis 61:597-612.

View

Appleby JC, Himmelweit F, Stuart-Harris CH (1951)
Immunization with influenza virus A vaccines. Comparision of intradermal and subcutaneous routes. Lancet 1:1384-1387.

View

Daniels M (1951)
Clinical evaluation of chemotherapy in tuberculosis. British Medical Bulletin 7:320-326.

View

Medical Research Council (1951)
The prevention of whooping-cough by vaccination. BMJ 1:1463-1471.

View

Daniels M, Hill AB (1952)
Chemotherapy of pulmonary tuberculosis in young adults: An analysis of the combined results of three medical research council trials. BMJ 1:1162-1168.

View

Fisher OD, Whitfield CR (1952)
Terramycin in the treatment of pneumonia in children. BMJ 2:864-865.

View

Nagpaul DR (1952)
Clinical trials with ‘Tibione’ in pulmonary tuberculosis. Indian Journal of Medicial Research 40:151-159.

View

Hammon W, Coriell LL, Stokes J (1952)
Evaluation of red cross gamma globulin as a prophylactic agent for poliomyelitis: 1. Plan of controlled field tests and results of 1951 pilot study in Utah. JAMA 150:739-749.

View

Miall WE, Oldham PD, Cochrane AL (1954)
The treatment of complicated pneumoconiosis with isoniazid. British Journal of Industrial Medicine 11:186-191.

View

Chalmers TC, Eckhardt RD, Reynolds WE, Cigarroa JG, Deane N, Reifenstein RW, Smith CW, Davidson CS (1955)
The treatment of acute infectious hepatitis. Controlled studies of the effects of diet, rest, and physical reconditioning on the acute course of the disease and on the incidence of relapses and residual abnormalities. Journal of Clinical Investigation 34: 1163-1235.

View

Franz WL, Sands GW, Heyl HL (1956)
Blood ascorbic acid level in bioflavinoid and ascorbic acid therapy of common cold. JAMA 162:1224-1226.

View

Tebrock HE, Arminio JJ, Johnston JH (1956)
Usefulness of bioflavinoids and ascorbic acid in treatment of common cold. JAMA 162:1227-1233.

View

Symposium on Clinical Trials RSM (1958)
Report of a meeting held at the Royal Society of Medicine, London on 25th April 1958.

View

Waife SO, Shapiro AP (1959)
The clinical evaluation of new drugs. New York: Hoeber-Harper.

View

Witts LJ (1959)
Medical surveys and clinical trials: some methods and applications of group research in medicine. Oxford: Oxford University Press.

View

Comstock GW (1962)
Isoniazid prophylaxis in an undeveloped area. American Review of Respiratory Diseases 86:810-822.

View

Hill AB (1962)
Alfred Watson Memorial Lecture: The Statistician in Medicine. Journal of the Institute of Actuaries 88:178-191. doi:10.1017/S0020268100014980

View

Horwitz O, Payne PG, Wilbek E (1966)
Epidemiologic basis for tuberculosis eradication. 4. The isoniazid trial in Greenland. Bulletin of the World Health Organisation 35:509-526.

View

Pollock TM, Bell JA, Hill AB, Cockburn WC, Cvjetanović B, Evans DG, Kostrzewski J, Schofield FD (1966)
Trials of Prophylactic agents for the control of communicable diseases: a guide to their organization and evaluation‎. Geneva: World Health Organization.

View

Ley HL (1969)
Antibiotic drugs: procedural and interpretive regulations. Federal Register Vol. 34, No. 180, pp14596-597.

View

Storey J, Rossi-Espagnet A, Mandel SPH, Matsushima T, Lietaert P, Thomas D, Brøgger S, Duby C, Gramiccia G (1973)
Sulfalene with pyrimethamine and chloroquine with pyrimethamine in single-dose treatment of Plasmodium falciparum infections. Bulletin of the World Health Organisation 49: 275-282.

View

Horwitz O, Magnus K (1974)
Epidemiologic evaluation of chemoprophylaxis against tuberculosis. American Journal of Epidemiology 99:333-342.

View

Chalmers TC (1975)
Effects of ascorbic acid on the common cold. An evaluation of the evidence. Amer J Med 58:532-6.

View

Chodak GW, Plaut ME (1977)
Use of systemic antibiotics for prophylaxis in surgery. A critical review. Archives of Surgery 112:326-334.

View

Baum ML, Anish DS, Chalmers TC, Sacks HS, Smith H, Fagerstrom RM (1981)
A survey of clinical trials of antibiotic prophylaxis in colon surgery: Evidence against further use of no-treatment controls. New England Journal of Medicine 305:795-799.

View

Black RE, Dykes AC, Anderson KE, Wells JG, Sinclair SP, Gary GW Jr, Hatch MH, Gangarosa EJ (1981)
Handwashing to prevent diarrhea in day-care centers American Journal of Epidemiology. 113:445-51.

View

Polk BF (1981)
Antimicrobial prophylaxis to prevent mixed bacterial infection. Journal of Antimicrobial Chemotherapy 8(suppl D):115-129.

View

Cone LA (1982)
A survey of prospective, controlled clinical trials of gentamicin, tobramycin, amikacin, and netilmicin. Clinical Therapeutics 5:155-1621.

View

Sutter EE, Ballard RC (1983)
Community participation in the control of trachoma in Gazankulu. Social Science & Medicine 17:22:1813-1817.

View

Vogt RL, Larue D, Klaucke DN, Jillson DA (1983)
Comparison of an active and passive surveillance system of primary care providers for Hepatitis, Measles, Rubella, and Salmonellosis in Vermont. American Journal of Public Health 73:795-7.

View

Yokley JM, Glenwick DS (1984)
Increasing the immunization of preschool children; An evaluation of applied community interventions. Journal of Applied Behavior Analysis 17:313-325.

View

Stanton BF, Clemens JD (1987)
An educational intervention for altering water-sanitation behaviors to reduce childhood diarrhea in urban Bangladesh. II. A randomized trial to assess the impact of the intervention on hygienic behaviors and rates of diarrhea. American Journal of Epidemiology 125:292-301.

View

Farr BM, Hendley JO, Kaiser DL, Gwaltney JM (1988)
Two randomized controlled trials of virucidal nasal tissues in the prevention of natural upper respiratory infections. Am J Epidemiol 128:1162-72.

View

Job-Spira N, Meyer L, Bouvet E, Janaud A, Spira A (1988)
The prevention of sexually transmitted diseases which affect fertility: methodological problems and initial results. European Journal of Obstetrics & Gynecology and Reproductive Biology 27:157-164.

View

Gyorkos TW, Frappier-Davignon L, MacLean JD, Viens P (1989)
Effect of screening and treatment on imported intestinal parasite infections: results from a randomized, controlled trial. American Journal of Epidemiology 129:753-61.

View

Seto WH, Ching PTY, Fung JPM, Fielding R (1989)
The role of communication in the alteration of patient-care practices in hospital-a prospective study. Journal of Hospital Infection 14:29-37.

View

Pennington E, Pennington S (1991)
Modifying chickenpox. BMJ 303:1614.

View

McCusker J, Stoddard Am, Zapka JG, Morrison CS, Zorn M, Lewis BF (1992)
AIDS education for drug abusers: Evaluation of short-term effectiveness. American Journal of Public Health 82:533-540.

View

Waller LA (1997)
A note on Harold S Diehl, randomization, and clinical trials. Controlled Clinical Trials 18: 180-183.

View

Connolly SJ, Philippon F, Longtin Y, Casanova A, Birnie DH, Exner DV, Dorian P, Prakash R, Alings M, Krahn AD (2013)
Randomized cluster crossover trials for reliable, efficient, comparative effectiveness testing: design of the Prevention of Arrhythmia Device Infection Trial (PADIT). Can J Cardiol 29:652-8.

View

Jefferson T, Jones MA, Doshi P, Del Mar CB, Hama R, Thompson MJ, Spencer EA, Onakpoya I, Mahtani KR, Nunan D, Howick J, Heneghan CJ (2014)
Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database of Systematic Reviews 2014, Issue 4. Art. No.: CD008965. DOI:10.1002/14651858.CD008965.pub4.

View

Stockwell MS, CaCamargo S, Ramakrishnan R, Holleran S, Findley SE, Kukafka R, Hofstetter AM, Fernandez N, Vawdrey DK (2015)
Registry-linked electronic influenza vaccine provider reminders: a cluster-crossover trial. Pediatrics. 135:e75-82.

View

Cohen D (2018)
Oxford TB vaccine study calls into question selective use of animal data. BMJ 360:j5845 doi: 10.1136/bmj.j5845

View

Horby P, Lim WS, Emberson J, Mafham M, Bell J, Linsell L, Staplin N, Brightling C, Ustianowski A, Elmahi E, Prudon B, Green C, Felton T, Chadwick D, Rege K, Fegan C, Chappell LC, Faust SN, Jaki T, Jeffrey K, Montgomery A, Rowan K, Juszcak E, Baillie JK, Haynes R, Landray MJ, on behalf of the RECOVERY Collaborative Group (2020)
Effect of Dexamethasone in Hospitalized Patients with COVID-19: Preliminary Report. medRχiv. Doi: https://doi.org/10.1101/2020.06.22.20137273

View

Horby P, Mafham M, Linsell L, Bell JL, Staplin N, Emberson JR, Wiselka M, Ustianowski A, Elmahi E, Prudon B, Whitehouse A, Felton T, Williams J, Faccenda J, Underwood J, Baillie JK, Chappell L, Faust SN, Jaki T, Jeffery K, Lim WS, Montgomery A, Rowan K, Tarning J, Watson JA, White NJ, Juszczak E, Haynes R, Landray MJ (2020)
Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19: Preliminary results from a multi-centre, randomized, controlled trial. doi: https://doi.org/10.1101/2020.07.15.20151852

View

RECOVERY Trial Team (2020)
Randomized Evaluation of COVID019 Therapy (RECOVERY). RECOVERY Central Coordinating Office, Oxford. www.recoverytrial.net

View

Pan H, Peto R, Karim QA, Alejandria M, Henao-Restrepo AM, García CH, Kieny MP, Malekzadeh R, Murthy S, Preziosi MP, Reddy S, Periago MR, Sathiyamoorthy V, Røttingen JA, Swaminathan S, WHO Solidarity trial consortium (2020)
Repurposed antiviral drugs for COVID-19 –interim WHO SOLIDARITY trial results. MedRxiv. doi: https://doi.org/10.1101/2020.10.15.20209817

View

D'Aquila RT, Hughes MD, Johnson VA, Fischl MA, Sommadossi JP, Liou SH, Timpone J, Myers M, Basgoz N, Niu M, Hirsch MS (2021)
Nevirapine, zidovudine, and didanosine compared with zidovudine and didanosine in patients with HIV-1 infection. A randomized, double- blind, placebo-controlled trial. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protocol 241 Investigators. Annals of Internal Medicine 124:1019-1030.

View

Bradley VC, Kuriwaki S, Isakov M, Sejdinovic D, Meng X, Flaxman S (2021)
Unrepresentative big surveys significantly overestimated US vaccine uptake. Nature 600, 695–700. https://doi.org/10.1038/s41586-021-04198-4.

View

Show


Pazzini A (1958).
Angelo Celli (1857-1914). JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Hróbjartsson A, Gøtzsche PC, Gluud C (1988).
The controlled clinical trial turns 100 years: Fibiger’s trial of serum treatment of diphtheria. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Yoshioka AY (1998).
Streptomycin, 1946: British central administration of supplies of a new drug of American origin with special reference to clinical trials in tuberculosis. Philosophy Thesis, University of London. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Armitage P† (2002).
Randomisation and alternation: a note on Diehl et al. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Loudon I (2002).
The use of historical controls and concurrent controls to assess the effects of sulphonamides, 1936-1945. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Loudon I (2002).
An early Medical Research Council controlled trial of vitamins for preventing infection. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Pollock JI (2003).
Clifford Wilson (1906-1997) and Martin Pollock (1914-1999). JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Tröhler U (2003).
Adolf Bingel (1879-1953), a member of the last generation of general internal physicians in Germany. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Armitage P† (2003).
Some recollections of the early years of the Medical Research Council (MRC) Statistical Research Unit. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Clarke M (2004).
The 1944 patulin trial of the British Medical Research Council: an example of how concerted common purpose can get reliable answers to important questions very quickly. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Diaz M, Neuhauser D (2004).
Lessons from using randomization to assess gold treatment for tuberculosis. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Gøtzsche PC (2004).
Niels Finsen’s treatment for lupus vulgaris. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Houston C (2004).
Ferguson’s BCG research – Canada’s first randomized clinical trial? JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Morabia A (2004).
Pierre-Charles-Alexandre Louis and the evaluation of bloodletting. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Crofton J† (2005).
Marc Daniels (1907-1953), a pioneer in establishing standards for clinical trial methods and reporting. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Huth EJ (2005).
Quantitative evidence for judgments on the efficacy of inoculation for the prevention of smallpox: England and New England in the 1700s. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Volmink J (2005).
The willow as a Hottentot (Khoikhoi) remedy for rheumatic fever. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Craft A (2006).
James Stansfeld (1917-1998). JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Crofton J† (2006).
John Crofton (1912-2009). JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Huth EJ (2006).
Benjamin Franklin’s (1706-1790), place in the history of medicine. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Jefferson T (2006).
Why the MRC randomized trials of whooping cough (pertussis) vaccines remain important more than half a century after they were done. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Marks HM† (2006).
The Kendrick-Eldering-(Frost) pertussis vaccine field trial. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Neuhauser D, Diaz M (2006).
Jesse GM Bullowa (1879-1943). JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Tansey EM (2006).
Philip Montagu D’Arcy Hart (1900-2006). JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Louis-Courvoisier M (2007).
An 18th century controlled trial prompted by a potential shortage of hospital beds. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Marks HM† (2007).
James Angus Doull and the well-controlled common cold. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Podolsky SH (2008).
Jesse Bullowa, specific treatment for pneumonia, and the development of the controlled clinical trial. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Sackett DL† (2008).
A 1955 clinical trial report that changed my career. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Shannon H (2008).
A statistical note on Karl Pearson’s 1904 meta-analysis. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Chalmers I, Toth B (2009).
19th century controlled trials to test whether belladonna prevents scarlet fever. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Dean ME (2009).
Comparative evaluation of homeopathy and allopathy within the Parisian hospital system, 1849-51. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Williams KJ (2009).
The introduction of ‘chemotherapy’ using arsphenamine – the first magic bullet. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Chalmers I (2010).
Joseph Asbury Bell (1904-1968). JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Chalmers I (2010).
Joseph Asbury Bell and the birth of randomized trials. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Chalmers I (2010).
Why the 1948 MRC trial of streptomycin used treatment allocation based on random numbers. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Cook H (2010).
Testing the effects of Jesuit’s bark in the Chinese Emperor’s court. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Gluud C (2010).
Danish contributions to the evaluation of serum therapy for diphtheria in the 1890s. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Klingberg MA (2010).
An epidemiologist’s journey from typhus to thalidomide, and from the Soviet Union to Seveso. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Löwy I (2010).
Martin Arrowsmith’s clinical trial: scientific precision and heroic medicine. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Opinel A, Gachelin G (2010).
French 19th century contributions to the development of treatments for diphtheria. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Tröhler U (2010).
Adolf Bingel’s blinded, controlled comparison of different anti-diphtheritic sera in 1918. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Chalmers I, Dukan E, Podolsky SH, Davey Smith G (2011).
The advent of fair treatment allocation schedules in clinical trials during the 19th and early 20th centuries. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Doyle D (2011).
Thomas John MacLagan (1838-1903). JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Doyle D (2011).
Thomas MacLagan’s 1876 demonstration of the dramatic effects of salicin in rheumatic fever. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Ferroni E, Jefferson T, Gachelin G (2011).
Angelo Celli and research on the prevention of malaria in Italy a century ago. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Gartlehner G, Stepper K (2011).
Julius Wagner-Jauregg: pyrotherapy, Simultanmethode, and ‘racial hygiene’. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Podolsky SH, Davey Smith G (2011).
Park’s story and Winters’ tale: alternate allocation clinical trials in turn of the Century America. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Gachelin G (2013).
The interaction of scientific evidence and politics in debates about preventing malaria in 1925. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

La Rochelle P, Julien A-S (2013).
How dramatic were the effects of handwashing on maternal mortality observed by Ignaz Semmelweis? JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Loudon I (2013).
Ignaz Phillip Semmelweis’ studies of death in childbirth. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Ramanna M (2014).
Nasarwanji Hormusji Choksy (1861-1939), a pioneer of controlled clinical trials. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Bryder L (2014).
The Medical Research Council and treatments for tuberculosis before streptomycin. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Toth B (2015).
Why the MRC Therapeutic Trials Committee didn’t introduce controlled clinical trials. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Dean ME (2015).
Selective suppression by the medical establishment of unwelcome research findings: The cholera treatment evaluation by the General Board of Health, London 1854. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Gachelin G, Garner P, Ferroni E, Tröhler U, Chalmers I (2016).
Evaluating Cinchona bark and quinine for treating and preventing malaria. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Lechuga RI, Castro AC (2016).
Dramatic effects of control measures on deaths from yellow fever in Havana, Cuba, in the early 1900’s. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Pollock JI (2017).
A controlled trial using a factorial design reported in 1946. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Garattini S (2018).
Italian controlled trials to assess prevention and treatment of malaria, 1900-1930s. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Pormann PE (2018).
Concepts of patient groups in 10th-century Iraq and Persia JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Jefferson T (2019).
Sponsorship bias in clinical trials – growing menace or dawning realisation? JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Tröhler U (2020)
Probabilistic thinking and the evaluation of therapies, 1700-1900. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Glasziou PP, Tikkinen KAO (2021).
The RECOVERY trial platform: a milestone in the development and execution of treatment evaluation during an epidemic. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Senn SJ, Chalmers I (2021).
Giving and taking: ethical treatment assignment in controlled trials. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Held L, Matthews RAJ (2022).
Paradigm lost: Carl Liebermeister and the development of modern medical statistics. JLL Bulletin: Commentaries on the history of treatment evaluation.

View